[Ip-health] Re: IGWG II: Limitation on Diseases

[mko]

David,

I find your comments surprising.  Surely a State Department employee
understands the difference between being in the room at the table, and
hearing from others second hand.

I hope the US delegation is in Geneva at taxpayer expense to represent all
of the citizens of the US, not just a specific corporate interest.

Kevin Outterson
Associate Professor of Law
Boston University

On 11/7/07 6:53 AM, "Hohman, David E" <HohmanDE@state.gov> wrote:

> Then don't complain that you don't have access.
>
>
>
> -----Original Message-----
>
> From: Judit Rius Sanjuan <judit.rius@keionline.org>
>
> To: Hohman, David E
>
> CC: Ip-health@lists.essential.org <Ip-health@lists.essential.org>
>
> Sent: Wed Nov 07 12:51:29 2007
>
> Subject: Re: [Ip-health] Re: IGWG II: Limitation on Diseases
>
>
>
> Dear Mr. Hohman,
>
>
>
> Thank you for your email. In this era of blackberries, sms, email and
>
> people going outside of the room to have a coffee, we have access to
>
> knowledge.
>
>
>
> I am sure the 49 pharmaceutical companies representatives are equally
>
> well informed, as are biotech who are actually in the room.
>
>
>
> Judit
>
>
>
> Hohman, David E wrote:
>
>> If you don't have access how do you know it's going on?
>
>>
>
>> -----Original Message-----
>
>> From: ip-health-admin@lists.essential.org
>> <ip-health-admin@lists.essential.org>
>
>> CC: Ip-health@lists.essential.org <Ip-health@lists.essential.org>
>
>> Sent: Wed Nov 07 12:31:25 2007
>
>> Subject: [Ip-health] Re: IGWG II: Limitation on Diseases
>
>>
>
>> It seems the footnote 1 may be coming back, they are currently
>
>> discussing it in one of the drafting rooms we (NGOS) do not have access =
to.
>
>>
>
>> Judit Rius Sanjuan wrote:
>
>>
>
>>> We have been informed that yesterday night one of the drafting group
>
>>> agreed to eliminate the footnote 1 included in the Secretariat Draft
>
>>> Global Strategy and Plan of Action.
>
>>>
>
>>> These are very good news because the footnote 1 included a
>
>>> unjustifiable limitation by listing the diseases that will be the
>
>>> focus of this global strategy and plan of action:
>
>>>
>
>>> Footnote eliminated: "The Commission=B9s definitions of Type I, Type II
>
>>> and Type III diseases, and the specific diseases on which this draft
>
>>> strategy focuses, are as follows: Type I diseases are incident in both
>
>>> rich and poor countries, with large numbers of vulnerable populations
>
>>> in each. The strategy will focus on the following Type I diseases,
>
>>> increasingly prevalent in developing countries: diabetes,
>
>>> cardiovascular disease and cancer. Type II diseases are incident in
>
>>> both rich and poor countries, but with a substantial proportion of the
>
>>> cases in poor countries. For the purposes of the strategy, the focus
>
>>> is on HIV/AIDS and tuberculosis. Type III diseases are those that are
>
>>> overwhelmingly or exclusively incident in developing countries. For
>
>>> the purposes of the strategy, the focus is on the nine neglected
>
>>> infectious diseases that disproportionately affect poor and
>
>>> marginalized populations prioritized by the UNICEF/UNDP/World Bank/WHO
>
>>> Special Programme for Research and Training in Tropical Diseases:
>
>>> Chagas disease, dengue and dengue haemorrhagic fever, leishmaniasis,
>
>>> leprosy, lymphatic filariasis, malaria, onchocerciasis,
>
>>> schistosomiasis and human African trypanosomiasis."
>
>>>
>
>>>
>
>>
>
>>
>
>> --
>
>> Judit Rius Sanjuan
>
>> Attorney
>
>> judit.rius@keionline.org
>
>>
>
>> Knowledge Ecology International (KEI)
>
>> www.keionline.org / www.cptech.org
>
>> 1621 Connecticut Ave, NW, Suite 500 Washington, DC 20009 USA
>
>> Tel.: +1.202.332.2670, Ext 18  Fax: +1.202.332.2673
>
>>
>
>> _______________________________________________
>
>> Ip-health mailing list
>
>> Ip-health@lists.essential.org
>
>> http://lists.essential.org/mailman/listinfo/ip-health
>
>>
>
>
>
>
>
> --
>
> Judit Rius Sanjuan
>
> Attorney
>
> judit.rius@keionline.org
>
>
>
> Knowledge Ecology International (KEI)
>
> www.keionline.org / www.cptech.org
>
> 1621 Connecticut Ave, NW, Suite 500 Washington, DC 20009 USA
>
> Tel.: +1.202.332.2670, Ext 18  Fax: +1.202.332.2673
>
>
>
> _______________________________________________
> Ip-health mailing list
> Ip-health@lists.essential.org
> http://lists.essential.org/mailman/listinfo/ip-health

Boston University School of Law
765 Commonwealth Ave., Boston  MA  02215
http://ssrn.com/author=3D340746